3Chen J, De S, Bminard Let al. Metastatic properties of prostate cancer cells are controlled by VEGF [ J] . Cell Commun Adhes, 2004, 11 (1): 1.
4Kusumanto YH, Weel VV, Mulder NH et al. Treatment with intramus- cular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double - blind randomized trial [J]. Hum Gene Ther, 2006, 17 (6) : 683.
5Gospodarowicz D.Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on3T3cell growth[J].Nature,1974,249(453):123-127.
6Skaletz-Rorowski A,Eschert H,Leng J,et al.PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells[J].Cardiovasc Res,2005,67(1):142-150.
7Takamiya M, Saigusa K, Nakayashike N, et al. Studies on mRNA expression of basic fibroblast growth factor in wound healing for wound age determination[ J]. Int J Legal Med, 2003, 117(1):46-47.
8Skatetz - Rorowski A, Eschert H, Leng J etal. PKC delta - induced activation of MAPK pathway is required for bFGF - stimulated proliferation of coronary smooth muscle cells [ J ] . Cardiovasc Res, 2005, 67 (1) : 142.
9Kusumanto YH, Weel VV, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double - blind randomized trial [ J ]. Hum Gene Ther, 2006,17 (6) : 683 - 691.
10Skalctz - Rorowski A, Eschert H, Leng J, et al. PKC delta - induced activation of MAPK pathway is required for bFGF - stimulated proliferation of coronary smooth muscle ceils [ J]. Cardiovasc Res ,2005 ,67 (1) :142.